

Sera Prognostics (NASDAQ:SERA) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Sera Prognostics (NASDAQ:SERA) through any online brokerage.
Other companies in Sera Prognostics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Sera Prognostics has a consensus price target of $6.00.
The stock price for Sera Prognostics (NASDAQ: SERA) is $2.03 last updated November 4, 2026 at 4:58 PM EST.
There are no upcoming dividends for Sera Prognostics.
Sera Prognostics does not have any upcoming earnings scheduled.
There is no upcoming split for Sera Prognostics.
Sera Prognostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and...